BSE Live
Nov 07, 16:01Prev. Close
377.30
Open Price
378.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 07, 15:49Prev. Close
377.00
Open Price
380.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
379.50 (314)
| Profit & Loss account of Kilitch Drugs (India) (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 18.44 | 14.21 | 35.41 | 109.14 | 148.28 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 3.42 | 2.53 | 2.28 | |
| Revenue From Operations [Net] | 18.44 | 14.21 | 31.99 | 106.61 | 146.00 | |
| Total Operating Revenues | 19.03 | 14.90 | 33.18 | 106.86 | 146.00 | |
| Other Income | 2.69 | 6.29 | 9.15 | 1.10 | 0.23 | |
| Total Revenue | 21.72 | 21.19 | 42.33 | 107.96 | 146.22 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 6.49 | 7.75 | 26.60 | 70.59 | 103.14 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.53 | -1.46 | 0.26 | 1.35 | -2.17 | |
| Employee Benefit Expenses | 3.13 | 2.86 | 3.03 | 5.00 | 5.35 | |
| Finance Costs | 0.00 | 0.00 | 0.02 | 2.95 | 3.69 | |
| Depreciation And Amortisation Expenses | 1.85 | 1.44 | 1.23 | 4.83 | 5.59 | |
| Other Expenses | 10.56 | 9.54 | 6.96 | 15.76 | 17.54 | |
| Total Expenses | 22.56 | 20.13 | 38.10 | 100.48 | 133.14 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -0.84 | 1.06 | 4.23 | 7.48 | 13.08 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | -15.53 | 0.00 | |
| Profit/Loss Before Tax | -0.84 | 1.06 | 4.23 | -8.05 | 13.08 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.00 | 0.00 | 21.05 | 2.61 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -0.66 | -0.10 | -0.01 | 0.00 | 0.01 | |
| Tax For Earlier Years | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | -0.66 | -0.11 | -0.01 | 21.05 | 2.62 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -0.19 | 1.18 | 4.24 | -29.10 | 10.46 | |
| Profit/Loss From Continuing Operations | -0.19 | 1.18 | 3.28 | 77.95 | 10.46 | |
| Profit/Loss For The Period | -0.19 | 1.18 | 3.28 | 77.95 | 10.46 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -0.14 | 0.89 | 2.48 | 58.91 | 7.91 | |
| Diluted EPS (Rs.) | -0.14 | 0.89 | 2.44 | 53.68 | 7.73 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 5.24 | 3.33 | 8.40 | |
| Indigenous Raw Materials | 0.00 | 6.29 | 21.62 | 68.61 | 96.70 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 39.70 | 1.32 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 6.44 | 0.22 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 300.00 | 10.00 |
20.05.2025
Kilitch Drugs Consolidated March 2025 Net Sales at Rs 61.23 crore, up 36.61% Y-o-Y
20.05.2025
Kilitch Drugs Standalone March 2025 Net Sales at Rs 56.30 crore, up 43.87% Y-o-Y
28.02.2025
Kilitch Drugs Consolidated December 2024 Net Sales at Rs 56.17 crore, up 76.65% Y-o-Y
17.02.2025
Kilitch Drugs Standalone December 2024 Net Sales at Rs 46.51 crore, up 56.27% Y-o-Y